Volba mezi inhibitory DPP4 a SGLT2 u diabetiků 2. typu nekompenzovaných na metforminu

Abstract

Souhrn s komentářem. Citace: Goldenberg RM, Choosing Dipeptidyl Peptidase-4 Inhibitors.

Sodium-glucose Cotransporter-2 Inhibitors, or Both, as Add-ons to Metformin: Patient Baseline Characteristics are Crucial. Clin Ther: 2017 Dec; 39(12): 2438-2447.

Keywords

• DPP4
• SGLT2